vs
STANDARD BIOTOOLS INC.（LAB）与LANDMARK BANCORP INC（LARK）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是LANDMARK BANCORP INC的1.0倍（$19.6M vs $18.8M），LANDMARK BANCORP INC净利率更高（27.0% vs -177.4%，领先204.4%），LANDMARK BANCORP INC同比增速更快（14.0% vs -11.5%），过去两年LANDMARK BANCORP INC的营收复合增速更高（13.1% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Landmark Bancorp Inc是一家总部位于美国的银行控股公司，运营Landmark National Bank，主要服务美国堪萨斯州的社区客户，提供全方位个人及商业银行服务，包括存款账户、住房抵押贷款、商业贷款及财富管理方案，服务对象涵盖个人消费者与本地中小企业。
LAB vs LARK — 直观对比
营收规模更大
LAB
是对方的1.0倍
$18.8M
营收增速更快
LARK
高出25.5%
-11.5%
净利率更高
LARK
高出204.4%
-177.4%
两年增速更快
LARK
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $18.8M |
| 净利润 | $-34.7M | $5.1M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | 27.0% |
| 营收同比 | -11.5% | 14.0% |
| 净利润同比 | -28.8% | 7.8% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABLARK
| Q1 26 | — | $18.8M | ||
| Q4 25 | — | $18.7M | ||
| Q3 25 | $19.6M | $18.2M | ||
| Q2 25 | $21.8M | $17.3M | ||
| Q1 25 | $40.8M | $16.5M | ||
| Q4 24 | — | $15.8M | ||
| Q3 24 | $22.1M | $15.9M | ||
| Q2 24 | $22.5M | $14.7M |
净利润LABLARK
| Q1 26 | — | $5.1M | ||
| Q4 25 | — | $4.7M | ||
| Q3 25 | $-34.7M | $4.9M | ||
| Q2 25 | $-33.5M | $4.4M | ||
| Q1 25 | $-26.0M | $4.7M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $-26.9M | $3.9M | ||
| Q2 24 | $-45.7M | $3.0M |
毛利率LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — |
营业利润率LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | 31.7% | ||
| Q3 25 | -168.5% | 33.4% | ||
| Q2 25 | -118.1% | 30.9% | ||
| Q1 25 | -80.8% | 34.7% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | -120.9% | 30.3% | ||
| Q2 24 | -134.5% | 24.5% |
净利率LABLARK
| Q1 26 | — | 27.0% | ||
| Q4 25 | — | 32.1% | ||
| Q3 25 | -177.4% | 27.1% | ||
| Q2 25 | -153.7% | 25.4% | ||
| Q1 25 | -63.8% | 28.5% | ||
| Q4 24 | — | 26.5% | ||
| Q3 24 | -122.0% | 24.8% | ||
| Q2 24 | -203.3% | 20.5% |
每股收益（稀释后）LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | $0.66 | ||
| Q3 25 | $-0.09 | $0.85 | ||
| Q2 25 | $-0.09 | $0.75 | ||
| Q1 25 | $-0.07 | $0.81 | ||
| Q4 24 | — | $0.47 | ||
| Q3 24 | $-0.07 | $0.68 | ||
| Q2 24 | $-0.12 | $0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $31.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | — |
| 总资产 | $539.6M | $1.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABLARK
| Q1 26 | — | $31.9M | ||
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — |
总债务LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — |
股东权益LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | $160.6M | ||
| Q3 25 | $399.7M | $155.7M | ||
| Q2 25 | $424.5M | $148.4M | ||
| Q1 25 | $454.6M | $142.7M | ||
| Q4 24 | — | $136.2M | ||
| Q3 24 | $489.3M | $139.7M | ||
| Q2 24 | $510.3M | $128.3M |
总资产LABLARK
| Q1 26 | — | $1.6B | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | $539.6M | $1.6B | ||
| Q2 25 | $557.0M | $1.6B | ||
| Q1 25 | $579.6M | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $681.5M | $1.6B | ||
| Q2 24 | $708.7M | $1.6B |
负债/权益比LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | — |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | $21.6M | ||
| Q3 25 | $-22.2M | $10.3M | ||
| Q2 25 | $-20.7M | $439.0K | ||
| Q1 25 | $-30.3M | $8.0M | ||
| Q4 24 | — | $14.2M | ||
| Q3 24 | $-27.9M | $8.1M | ||
| Q2 24 | $-39.0M | $4.4M |
自由现金流LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | $21.0M | ||
| Q3 25 | $-23.1M | $10.1M | ||
| Q2 25 | $-22.6M | $354.0K | ||
| Q1 25 | $-35.3M | $8.0M | ||
| Q4 24 | — | $11.9M | ||
| Q3 24 | $-30.1M | $7.8M | ||
| Q2 24 | $-41.0M | $3.8M |
自由现金流率LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | 112.5% | ||
| Q3 25 | -118.1% | 55.4% | ||
| Q2 25 | -103.6% | 2.0% | ||
| Q1 25 | -86.6% | 48.4% | ||
| Q4 24 | — | 75.6% | ||
| Q3 24 | -136.4% | 49.3% | ||
| Q2 24 | -182.2% | 25.6% |
资本支出强度LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | 3.2% | ||
| Q3 25 | 4.5% | 1.4% | ||
| Q2 25 | 8.7% | 0.5% | ||
| Q1 25 | 12.4% | 0.3% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 10.2% | 1.8% | ||
| Q2 24 | 8.6% | 4.2% |
现金转化率LABLARK
| Q1 26 | — | — | ||
| Q4 25 | — | 4.56× | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 1.71× | ||
| Q4 24 | — | 4.34× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 1.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
LARK
暂无分部数据
